Spyre Therapeutics Inc at Citi Biopharma Back to School Summit Transcript
I am Sam Semenko. I'm one of the senior biotech analysts here at Citi, and it is my pleasure to be hosting Spire Therapeutics at Citi's 2026 Biopharma Back to School Summit. I'm joined by Cameron Turtle, CEO of Spire. Cameron, welcome and thank you so much for being here.
Appreciate you having us.
So maybe we just start a little bit high level. You made a ton of progress this year across the pipeline. We still do have a couple more readouts.
Through the rest of the year. Can you just level set where the company stands today and what we can expect from you through your end?
Sure. So broadly, our goal is to develop products that elevate the standard of care in autoimmune diseases.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
